Clinical Trial Update: A Prospective Multicenter Clinical Study of SCCG Protocol and ctDNA 5hmc in Predicting the Chemotherapy Sensitivity and Monitoring the Recurrence and Metastasis of Hepatoblastoma in Children and Adolescents [Phase 2]

View source ↗

Summary

Phase 2 multicenter study evaluating SCCG protocol and ctDNA 5hmc for predicting chemotherapy sensitivity and monitoring recurrence/metastasis in hepatoblastoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatoblastoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatoblastoma | Phase 2 | Status: RECRUITING